Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands

@article{Schouten2014ResponseEA,
  title={Response evaluation after chemoradiotherapy for advanced staged oropharyngeal squamous cell carcinoma: a nationwide survey in the Netherlands},
  author={C. S. Schouten and O. Hoekstra and C. R. Leemans and J. Castelijns and R. Bree},
  journal={European Archives of Oto-Rhino-Laryngology},
  year={2014},
  volume={272},
  pages={3507-3513}
}
  • C. S. Schouten, O. Hoekstra, +2 authors R. Bree
  • Published 2014
  • Medicine
  • European Archives of Oto-Rhino-Laryngology
    • Following failure of chemoradiotherapy (CRT) for advanced staged oropharyngeal squamous cell carcinomas (OPSCC), residual tumor can often be treated successfully with salvage surgery, if detected early. Current clinical practice in the VU University Medical Center is to perform routine response evaluation, i.e., examination under general anesthesia (EUA), 12 weeks after treatment. However, in the Netherlands there is no consensus on response evaluation in patients with advanced oropharyngeal… CONTINUE READING
    View on Springer
    ncbi.nlm.nih.gov
    10 Citations
    Highly Influencial Citations
    1
    Background Citations
    1
    Methods Citations
    2
    10 Citations
    Citation Type

    Citation Type

    A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response
    • 4
    CT-based follow-up following radiotherapy or radiochemotherapy for locally advanced head and neck cancer; outcome and development of a prognostic model for regional control.
    • 3
    Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F–FDG-PET-CT and/or diffusion-weighted MRI
    • 3
    Surgical rescue for persistent head and neck cancer after first-line treatment
    • 3
    • PDF
    Post-treatment 18F-FDG-PET/CT versus contrast-enhanced CT in patients with oropharyngeal squamous cell carcinoma: comparative effectiveness study
    • 3
    The Role of Positron Emission Tomography/Computed Tomography Imaging in Head and Neck Cancer after Radical Chemoradiotherapy: a Single Institution Experience.
    • 8
    Qualitative interpretation of PET scans using a Likert scale to assess neck node response to radiotherapy in head and neck cancer
    • 22
    • Highly Influenced
    FDG-PET-CT and/or diffusion-weighted MRI
    Advanced Imaging Techniques of the Skull Base.
    • 1
    C HAPTER 8 C OST-EFFECTIVENESS OF RESPONSE EVALUATION AFTER CHEMORADIOTHERAPY IN PATIENTS WITH ADVANCED OROPHARYNGEAL CANCER USING 18 F-FDG-PET-CT AND / OR DIFFUSION-WEIGHTED MRI

    References

    SHOWING 1-10 OF 36 REFERENCES
    Survival Impact of Planned Restaging and Early Surgical Salvage Following Definitive Chemoradiation for Locally Advanced Squamous Cell Carcinomas of the Oropharynx and Hypopharynx
    • 53
    • Highly Influential
    Detection of locoregional recurrent head and neck cancer after (chemo)radiotherapy using modern imaging.
    • 88
    Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
    • 2,134
    18F-FDG PET as a Routine Posttreatment Surveillance Tool in Oral and Oropharyngeal Squamous Cell Carcinoma: A ProspectiveStudy
    • 62
    • PDF
    Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
    • 4,260
    • PDF
    CT findings at the primary site of oropharyngeal squamous cell carcinoma within 6-8 weeks after definitive radiotherapy as predictors of primary site control.
    • 35
    Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response
    • 129
    Role of 18FFDG PET/CT in the treatment of head and neck cancers: posttherapy evaluation and pitfalls.
    • 36
    Head and neck cancer
    • 719
    • PDF
    Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    • 104